{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:06:40Z","timestamp":1790791600498,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional","award":["PI14\/00947"],"award-info":[{"award-number":["PI14\/00947"]}]},{"name":"Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional","award":["PI17\/00949"],"award-info":[{"award-number":["PI17\/00949"]}]},{"name":"Instituto de Salud Carlos III of Spain TERCEL funds","award":["RD12\/0019\/0011"],"award-info":[{"award-number":["RD12\/0019\/0011"]}]},{"name":"Instituto de Salud Carlos III of Spain CIBENED funds","award":["CB06\/05\/1105"],"award-info":[{"award-number":["CB06\/05\/1105"]}]},{"name":"Asociaci\u00f3n Adelante de La Roda"},{"name":"Plataforma Afectados por la ELA"},{"name":"Asociaci\u00f3n Juntos Venceremos ELA"},{"name":"AVPA Zaragoza"},{"name":"Fondazione Roma and Agenzia Spaziale Italiana"},{"name":"Instituto de Salud Carlos III of Spain TERCEL funds","award":["RD16\/0011\/0035"],"award-info":[{"award-number":["RD16\/0011\/0035"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210752","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T18:41:32Z","timestamp":1547491292000},"page":"e0210752","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS"],"prefix":"10.1371","volume":"14","author":[{"given":"Amaya","family":"Rando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Martinez-Muriana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Musaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-1737","authenticated-orcid":true,"given":"Janne M.","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"O Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?","volume":"9","author":"D Petrov","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clinthera.2014.12.020","article-title":"Therapeutic development in amyotrophic lateral sclerosis","volume":"37","author":"M Bucchia","year":"2015","journal-title":"Clin Ther"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/mt.2010.271","article-title":"CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit","volume":"19","author":"A Henriques","year":"2011","journal-title":"Mol Ther"},{"issue":"Pt 12","key":"ref5","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/brain\/awn243","article-title":"Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis","volume":"131","author":"C Pitzer","year":"2008","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1742-2094-8-74","article-title":"Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis","volume":"8","author":"E Pollari","year":"2011","journal-title":"Journal of neuroinflammation"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000446113","article-title":"Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitro","volume":"17","author":"A Rando","year":"2017","journal-title":"Neurodegener Dis"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"DB Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0006-2952(97)00040-3","article-title":"An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug","volume":"53","author":"K Ghoshal","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"e78172","DOI":"10.1371\/journal.pone.0078172","article-title":"New insights into the RNA-based mechanism of action of the anticancer drug 5'-fluorouracil in eukaryotic cells","volume":"8","author":"L Mojardin","year":"2013","journal-title":"PLoS One"},{"issue":"25","key":"ref11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199412223312516","article-title":"Transgenic-mouse model of amyotrophic lateral sclerosis","volume":"331","author":"ME Gurney","year":"1994","journal-title":"N Engl J Med"},{"key":"ref12","article-title":"Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis","author":"S Olivan","year":"2014","journal-title":"Exp Anim"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"ref14","unstructured":"Leitner M, Menzies S, Lutz C. Working with ALS Mice. Guidelines for preclinical testing & colony management."},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2011.03.096","article-title":"Housekeeping gene expression in myogenic cell cultures from neurodegeneration and denervation animal models","volume":"407","author":"R Manzano","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s13311-012-0140-y","article-title":"Sigma-1R agonist improves motor function and motoneuron survival in ALS mice","volume":"9","author":"R Mancuso","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00109-009-0556-y","article-title":"Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy","volume":"88","author":"M Moreno-Igoa","year":"2010","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood.V98.4.1019","article-title":"Thrombocytopenic c-mpl(-\/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response","volume":"98","author":"J Levin","year":"2001","journal-title":"Blood"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood.V76.3.508.508","article-title":"Prolonged thrombocytosis in mice after 5-fluorouracil results from failure to down-regulate megakaryocyte concentration. An experimental model that dissociates regulation of megakaryocyte size and DNA content from megakaryocyte concentration","volume":"76","author":"PJ Chenaille","year":"1990","journal-title":"Blood"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"LR Fischer","year":"2004","journal-title":"Exp Neurol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.freeradbiomed.2010.01.014","article-title":"Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis","volume":"48","author":"B Halter","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000324159","article-title":"Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis","volume":"8","author":"R Manzano","year":"2011","journal-title":"Neuro-degenerative diseases"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e32632","DOI":"10.1371\/journal.pone.0032632","article-title":"Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice","volume":"7","author":"AC Calvo","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2044-5040-1-3","article-title":"Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation","volume":"1","author":"G Dobrowolny","year":"2011","journal-title":"Skelet Muscle"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/blood.V89.10.3596","article-title":"Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment","volume":"89","author":"TD Randall","year":"1997","journal-title":"Blood"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood.V81.6.1497.1497","article-title":"Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo","volume":"81","author":"VF Quesniaux","year":"1993","journal-title":"Blood"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.stem.2013.01.017","article-title":"Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging","volume":"12","author":"I Beerman","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"e20143","DOI":"10.1371\/journal.pone.0020143","article-title":"Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells","volume":"6","author":"A Udelnow","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2125.2008.03243.x","article-title":"Hormesis and medicine","volume":"66","author":"EJ Calabrese","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"408681","DOI":"10.1155\/2013\/408681","article-title":"Redox regulation in amyotrophic lateral sclerosis","volume":"2013","author":"S Parakh","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fncel.2014.00131","article-title":"The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis","volume":"8","author":"E Pollari","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1742-7843.2010.00621.x","article-title":"Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice","volume":"108","author":"S Numazawa","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/17482968.2010.491867","article-title":"Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice","volume":"11","author":"DJ Amante","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"issue":"39","key":"ref35","doi-asserted-by":"crossref","first-page":"16398","DOI":"10.1073\/pnas.1102645108","article-title":"Intermolecular transmission of superoxide dismutase 1 misfolding in living cells","volume":"108","author":"LI Grad","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"e35050","DOI":"10.1371\/journal.pone.0035050","article-title":"Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis","volume":"7","author":"E Pokrishevsky","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1073\/pnas.1312245111","article-title":"Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms","volume":"111","author":"LI Grad","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","first-page":"1","article-title":"Small molecules that block propagation of sod1 misfolding in living cells","volume":"14","author":"D Airey","year":"2014","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"e0184384","DOI":"10.1371\/journal.pone.0184384","article-title":"Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells","volume":"12","author":"E Pokrishevsky","year":"2017","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T02:10:18Z","timestamp":1720923018000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210752"}},"subtitle":[],"editor":[{"given":"Hoon","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210752","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]}}}